VHCP Management as of June 30, 2015
Portfolio Holdings for VHCP Management
VHCP Management holds 18 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anacor Pharmaceuticals In | 25.6 | $91M | 1.2M | 77.43 | |
| Dbv Technologies (DBVTF) | 10.9 | $39M | 694k | 55.75 | |
| Gw Pharmaceuticals Plc ads | 10.8 | $38M | 312k | 122.84 | |
| Heron Therapeutics (HRTX) | 9.6 | $34M | 1.1M | 31.16 | |
| Coherus Biosciences (CHRS) | 7.1 | $25M | 870k | 28.90 | |
| Avalanche Biotechnologies In | 6.3 | $23M | 1.4M | 16.24 | |
| Zafgen | 5.3 | $19M | 542k | 34.63 | |
| Ascendis Pharma A S (ASND) | 4.0 | $14M | 811k | 17.68 | |
| ARCA biopharma | 3.5 | $12M | 11M | 1.15 | |
| Lipocine | 3.1 | $11M | 1.3M | 8.58 | |
| Flamel Technologies | 3.0 | $11M | 500k | 21.19 | |
| Alcobra | 2.8 | $9.8M | 1.5M | 6.54 | |
| Cynapsus Therapeutics | 1.6 | $5.9M | 367k | 16.03 | |
| BioCryst Pharmaceuticals (BCRX) | 1.6 | $5.6M | 374k | 14.93 | |
| D Stemline Therapeutics | 1.5 | $5.3M | 451k | 11.77 | |
| Zs Pharma | 1.5 | $5.2M | 100k | 52.39 | |
| Juno Therapeutics | 1.4 | $4.8M | 90k | 53.33 | |
| Ocera Therapeutics | 0.8 | $2.7M | 704k | 3.80 |
